Related Experiment Videos

Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole

Insights

Trimethoprim (TMP) and sulfamethoxazole (SMZ) combination therapy effectively inhibited Haemophilus influenzae growth. This antibiotic combination showed greater efficacy than individual drugs, impacting both ampicillin-susceptible and resistant strains.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Haemophilus influenzae is a significant human pathogen.
  • Antibiotic resistance in H. influenzae poses a clinical challenge.
  • Trimethoprim (TMP) and sulfamethoxazole (SMZ) are commonly used antibiotics.

Purpose of the Study:

  • To evaluate the in vitro inhibitory effect of TMP and SMZ, alone and in combination, against H. influenzae.
  • To compare the efficacy of the TMP/SMZ combination with individual agents.
  • To assess susceptibility differences between ampicillin-susceptible and resistant strains, and between different H. influenzae serotypes.

Main Methods:

  • The study involved 34 strains of H. influenzae.
  • Growth inhibition was assessed by comparing viable colony counts in drug-containing media versus drug-free controls after 18-hour incubation.
  • A modified, thymidine-deficient Levinthal broth was utilized.

Main Results:

  • The combination of TMP/SMZ (1.25/25 µg/ml) achieved a ≥100-fold reduction in colony-forming units for all tested H. influenzae isolates compared to controls.
  • TMP/SMZ demonstrated significantly greater inhibition than either TMP or SMZ used alone.
  • Both ampicillin-susceptible and ampicillin-resistant strains exhibited equal susceptibility to TMP/SMZ.
  • Nontypable H. influenzae strains showed greater growth inhibition by TMP/SMZ than type b strains.

Conclusions:

  • The combination of trimethoprim and sulfamethoxazole is highly effective in inhibiting the in vitro growth of Haemophilus influenzae.
  • TMP/SMZ offers a potent therapeutic option against H. influenzae, including ampicillin-resistant strains.
  • Nontypable H. influenzae may be more susceptible to TMP/SMZ than type b strains, suggesting potential strain-specific efficacy.

Related Concept Videos